CCL Products Q2 FY27: Sustaining Volume Momentum & Margin Expansion
After a 61% profit surge in Q1 on 13.8% revenue growth and 105bp margin expansion, the Street watches for continued operational leverage and premium-product momentum heading into the September quarter. The company trades 22% below consensus target.
The Setup
CCL Products delivered a 61% net profit surge in Q1 FY27 (ended June 30, 2026) on the back of 13.76% revenue growth and 105bp EBITDA margin expansion. The driver was clear: ~20% volume growth from specialty coffee demand plus the beginning of operating leverage from capacity expansions in India and Vietnam that came online during FY26. Net debt fell ₹100 Cr to ₹963 Cr, signaling strong cash conversion. Now the Street watches Q2—will the volume growth persist, and will margins hold or expand further as the company scales those new plants?
~₹1,160 Cr
in line with H1 run-rate; ~10–12% YoY growth on-plan
~15–16%
maintain Q1's 16.12% or contract 100bp—test of input-cost pass-through
~₹105–110 Cr
on-plan; Q1 saw 61% jump vs ₹72.4 Cr YoY—growth rate may moderate
FY27 EPS ~₹38.13
18% growth expected vs FY26; quarterly numbers guide Q2 run-rate
What a strong Q2 looks like: Revenue in-line or up 12–14% YoY (₹1,150–₹1,200 Cr), EBITDA margin holds ≥15.5%, net profit ≥₹105 Cr. Volume momentum intact, no guidance reset, and manageable commodity (coffee/chicory) costs. What a weak print would signal: Revenue below ₹1,120 Cr (sub–10% growth), margin compression below 15%, or profit miss >10%. Such an outcome would flag volume deceleration, input inflation not yet passed through, or inventory drag.
On Track?
CCL's full-year FY27 guide is intact. Analysts model ₹4,850 Cr revenue (9.3% FY27 growth) and 30.5% profit growth, implying a quarterly cadence of ₹1,200–₹1,250 Cr with expanding margins as capacity ramp stabilizes. Q1 already beat this—delivering ₹1,200 Cr in revenue and a 61% profit surge. For Q2–Q4, a more moderate 20–25% profit growth is reasonable as the year-over-year comparisons stiffen. The real test: can the company sustain volume momentum (the driver of Q1's ₹240M YoY revenue lift) and avoid a margin squeeze as scale increases and input costs stabilize?
What the Street Says
Since Q1 (Jul 2026)
Corporate actions: Board approved a ₹3 final dividend on July 27, 2026, with September 01 as record date. The 65th Annual General Meeting held on September 08, 2026. Trading window for insiders closed on September 28 for Q2 results, reopening post-disclosure. No material insider trading, pledges, or related-party deals flagged in recent filings—routine governance. Operationally: No guidance updates or business alerts filed; the company is in quiet period until October 15 board meeting.
What to Watch on October 15
1 · Volume & Revenue Momentum
Did the ~20% volume growth in Q1 sustain? If Q2 revenue is <₹1,100 Cr or <10% YoY, volume has stalled. Listen closely to management commentary on end-market demand (institutional + retail) and export markets.
2 · EBITDA Margin & Input Costs
Q1 saw 105bp expansion to 16.12% EBITDA margin. Watch if Q2 holds or contracts. Any margin miss (<15%) suggests coffee/chicory cost inflation outpacing price realization. Guidance on FY27 margin ceiling critical.
3 · Capacity Utilization & Operating Leverage
Management may quantify Vietnam plant ramp and India brownfield expansion ROI. Any delay in utilization or capex guidance revision would be a red flag for H2 expectations.
4 · Debt Reduction & Cash Flow
Net debt fell ₹100 Cr in Q1 to ₹963 Cr. Track Q2 deleveraging; strong cash generation supports reinvestment and shareholder returns.
CCL Products goes into its October 15 board meeting after a stellar Q1—a 61% profit surge on strong volume and margin expansion has set a high bar. The Street sees 28% upside in the stock, predicated on sustained specialty-coffee momentum, continued margin improvement, and operating leverage from new capacity. Q2 is the test: can the company hold volume growth, sustain or expand margins, and confirm that full-year FY27 guidance of 9% revenue and 30% profit growth remains on track? Expect the market to react sharply to any hint of volume softness or margin compression; hold or miss on both counts, and the consensus case remains intact.